Global Recombinant Proteins Market Estimated to Grow with 8.39%

The global Recombinant Proteins market was valued at US$ 612.28 million in 2019 and it is expected to reach US$ 1042.95 million by the end of 2026, growing at a CAGR of 8.39% during 2020-2026.

Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.

The main drivers for the use of recombinant proteins are: low availability of native protein (e.g. the annual use of amylase and xylose isomerase is over 95,000 tons each); livestock infections for the production of vaccines and subsequent economic loss; immune responses to animal proteins after injection (e.g. insulin); and reproducibility of protein production in relation to its quality.

Global Recombinant Proteins Market- Key Players

Abcam PLC, R&D Systems, Miltenyi Biotec, Merck KGaA, ThermoFisher Scientific, GE Healthcare, Lonza, Eurogentec (Kaneka Corporation), PeproTech, BPS Bioscience, Reprocell, Abnova Corporation, GenScript Biotech Corporation, ProSpec Tany TechnoGene, are some key suppliers analyzed in the report. Abcam is the largest supplier and accounts for about 13% market share. The followers include R&D Systems and Miltenyi Biotec, both owning more than 9% market share.

Global Recombinant Proteins Market: Segmental Analysis

Depending on the type of the protein, recombinant proteins are classified into hormones, growth factor, cytokines, plasma protein factor, recombinant metabolic enzymes, Immune Checkpoint Regulators and others. Cytokines, the major category of Recombinant Proteins, was valued at 160.28 USD million in 2019 and will grow at a CAGR of 8.55% from 2020 to 2026, and will reach 275.02 USD million in 2026.

Read More Information: https://www.qyresearch.com/index/detail/2673632/recombinant-protein-therapeutics

About Us:

QYResearch provides Market Research Reports for clients all over the world. As of now, QYResearch data as following:

62000 + Clients(cover 100% the world strong 500 companies and most industries’ leading players such as TOP5 players)

7800 + Experts(most of them with more than 15 years’ experience in their industry and professional knowledge both in market and technology)

300 + Data Base(40% government related data base, 30% third part data base, 10% international agencies data base, 30% technology and market data base)

2 Million + Reports(cover almost all industries and most detailed products such as product model level research reports, where you can find all what you need in one shop)

1000 + Custom Research Projects(most clients need custom research service and QYResearch keeps offering good and depth service for them)

30 + Roles Data Interview Checking System(only QYResearch uses such interview system with more than 30 roles in order to confirm the data reliability)

13 + Years focus market research and continues to support the client success.

Media Contact:

Rahul Singh - Digital Marketing Director

Contact: +91 7028 920 828 +81-903-800-9273 +86-108-294-5717

Email: rahul@qyresearch.com

Sales Contact US:

USA Registered Office: QY Research, INC.

17890 Castleton, Suite 369,

City of industry, CA - 91748

Phone: +1-626-295-2442

Emails – enquiry@qyrsearch.com

Web – www.qyresearch.com